Sanofi Obtains License for French Company's Antibody Engineering Platform - Labiotech.eu
Sanofi Obtains License for French Company's Antibody Engineering Platform Labiotech.euSanofi has licensed French biotech Biomunex' antibody technology, which has the potential to develop new immunotherapy treatments such as for cancer and ...